NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer

NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer

BackgroundPatients with early-stage laryngeal cancer, even stage T1-2N0, are at considerable risk of recurrence and death. The genetic and immunologic characteristics of recurrent laryngeal cancer remain unclear.MethodsA total of 52 T1-2N0 laryngeal cancer patients were enrolled. Of these, 42 tissue...

Full description

Bibliographic Details
Main Authors:	Xiao-yang Gong, Hai-bin Chen, Li-qing Zhang, Dong-sheng Chen, Wang Li, Dong-hui Chen, Jin Xu, Han Zhou, Le-le Zhao, Yun-jie Song, Ming-zhe Xiao, Wang-long Deng, Chuang Qi, Xue-rong Wang, Xi Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Immunology
Subjects:	T1-2N0 laryngeal cancer relapse tumor mutation burden NOTCH1 mutation tumor immunity molecular alterations
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.920253/full

Similar Items

NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
by: Huang Q, et al.
Published: (2023-12-01)

Effect of Notch1 signaling on cellular proliferation and apoptosis in human laryngeal carcinoma
by: Dawei Li, et al.
Published: (2022-08-01)

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma
by: Luochengling Xiang, et al.
Published: (2020-09-01)

The prognostic value of tumor mutational burden related 6-gene-based Risk Score in laryngeal cancer patients
by: Dong Yang, et al.
Published: (2022-11-01)

Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
by: Hao Chen, et al.
Published: (2019-05-01)

Corrigendum: Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
by: Hao Chen, et al.
Published: (2019-07-01)

Associating somatic mutations to clinical outcomes: a pan-cancer study of survival time
by: Paul Little, et al.
Published: (2019-05-01)

Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts
by: Sonia Minuzzo, et al.
Published: (2023-09-01)

Association of CSMD1 with Tumor Mutation Burden and Other Clinical Outcomes in Gastric Cancer
by: Wang X, et al.
Published: (2021-11-01)

Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas
by: Qing Zhang, et al.
Published: (2023-07-01)

POLE/POLD1 mutation and tumor immunotherapy
by: Xiaoting Ma, et al.
Published: (2022-07-01)

NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma
by: Pooja A. Shah, et al.
Published: (2020-12-01)

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer
by: Weikai Xiao, et al.
Published: (2021-04-01)

Unraveling the Heterogeneous Mutational Signature of Spontaneously Developing Tumors in MLH1<sup>−/−</sup> Mice
by: Yvonne Saara Gladbach, et al.
Published: (2019-10-01)

Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond
by: Federico Pozzo, et al.
Published: (2022-06-01)

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
by: He Ba, et al.
Published: (2021-11-01)

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
by: Peipei Wang, et al.
Published: (2021-04-01)

MDN1 Mutation Is Associated With High Tumor Mutation Burden and Unfavorable Prognosis in Breast Cancer
by: Shuai Hao, et al.
Published: (2022-03-01)

Review of Immunogenomics and the Role of Tumor Mutational Burden as a Biomarker for Immunotherapy Response
by: Javier Ros, et al.
Published: (2019-10-01)

Metastatic clear-cell renal cell carcinoma: a frequent NOTCH1 mutation predictive of response to anti-NOTCH1 CB-103 treatment
by: Thi Oanh Bui, et al.
Published: (2023-05-01)

Multiomics analysis of tumor mutational burden across cancer types
by: Lin Li, et al.
Published: (2021-01-01)

Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer
by: Hao Chen, et al.
Published: (2020-01-01)

A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma
by: Congkuan Song, et al.
Published: (2021-01-01)

CCND1 Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment
by: Jun Liu, et al.
Published: (2022-07-01)

Deep Genomic Sequencing of Bladder Urothelial Carcinoma in Southern Chinese Patients: A Single-Center Study
by: Dong-Yang Li, et al.
Published: (2021-05-01)

Case report: Remarkable response to a novel combination of mitotane, etoposide, paraplatin, and sintilimab in a patient with metastatic adrenocortical carcinoma
by: Yan Weng, et al.
Published: (2023-09-01)

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker
by: Qiguan Dong, et al.
Published: (2022-09-01)

Gallbladder Cancer: Current Insights in Genetic Alterations and Their Possible Therapeutic Implications
by: Hendrien Kuipers, et al.
Published: (2021-10-01)

Quantified pathway mutations associate epithelial-mesenchymal transition and immune escape with poor prognosis and immunotherapy resistance of head and neck squamous cell carcinoma
by: Yuhong Huang, et al.
Published: (2024-02-01)

NOTCH1-Related Leukoencephalopathy: A Novel Variant and Literature Review
by: Stefania Della Vecchia, et al.
Published: (2024-03-01)

SUMOylation Pattern Predicts Prognosis and Indicates Tumor Microenvironment Infiltration Characterization in Bladder Cancer
by: Qi-Dong Xia, et al.
Published: (2022-03-01)

Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden
by: Mengyao Dai, et al.
Published: (2023-03-01)

Research Progress on Heterogeneity of Tumor Mutation Burden in Patients with  Non-small Cell Lung Cancer
by: Abdurazik MIHRAY, et al.
Published: (2021-04-01)

BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancers
by: Huiping Shi, et al.
Published: (2024-01-01)

A Molecular Test for Quantifying Functional Notch Signaling Pathway Activity in Human Cancer
by: Kirsten Canté-Barrett, et al.
Published: (2020-10-01)

Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8+ T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma
by: Zhang C, et al.
Published: (2022-04-01)

Rare Combined Small Cell Lung Carcinoma and Lung Squamous Cell Carcinoma Response to PD-1 Inhibitor as Third-Line Therapy: A Case Report
by: Liu Z, et al.
Published: (2023-02-01)

Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing
by: Hui Cai, et al.
Published: (2019-06-01)

Uncovering BTB and CNC Homology1 (BACH1) as a Novel Cancer Therapeutic Target
by: Zheming Liu, et al.
Published: (2022-05-01)

NOTCH1 Aberrations in Chronic Lymphocytic Leukemia
by: Emanuela Rosati, et al.
Published: (2018-06-01)